Ignite Creation Date:
2024-05-06 @ 7:19 PM
Last Modification Date:
2024-10-26 @ 3:04 PM
Study NCT ID:
NCT05964452
Status:
RECRUITING
Last Update Posted:
2023-09-21
First Post:
2023-07-17
Brief Title:
Efficacy of Methimazole Dosing Algorithm
Sponsor:
Cook County Health
Organization:
Cook County Health
Study Overview
Official Title:
The Efficacy of Cook County Healths Methimazole Dosing Algorithm in the Setting of ne Onset Graves Hyperthyroidism
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To prospectively study the efficacy and safety of the Cook County Health CCH methimazole MMI dosing algorithm in the setting of new onset Graves disease
Detailed Description:
To conduct a prospective observational study in 60 patients with newly diagnosed Graves disease who are either methimazole naive or who have been initiated on MMI within previous 4-6 weeks per CCH algorithm and assess for efficacy and safety of MMI dosing administered Study group size is based on 90 power and projected efficacy of 70 patients reaching target
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None